These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28053362)

  • 1. Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.
    Smit GS; Apers L; Arrazola de Onate W; Beutels P; Dorny P; Forier AM; Janssens K; Macq J; Mak R; Schol S; Wildemeersch D; Speybroeck N; Devleesschauwer B
    Bull World Health Organ; 2017 Jan; 95(1):27-35. PubMed ID: 28053362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis in asylum seekers in Belgium. VRGT (Flemish Lung and Tuberculosis Association).
    Van den Brande P; Uydebrouck M; Vermeire P; Demedts M
    Eur Respir J; 1997 Mar; 10(3):610-4. PubMed ID: 9072993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of targeted screening for active pulmonary tuberculosis among asylum-seekers: A modelling study with screening data from a German federal state (2002-2015).
    Wahedi K; Biddle L; Bozorgmehr K
    PLoS One; 2020; 15(11):e0241852. PubMed ID: 33151980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis screening of asylum seekers: 1 years' experience at the Dover Induction Centres.
    Harling R; Pearce M; Chandrakumar M; Mueller K; Hayward A
    Public Health; 2007 Nov; 121(11):822-7. PubMed ID: 17645899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
    Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
    BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations.
    Dasgupta K; Schwartzman K; Marchand R; Tennenbaum TN; Brassard P; Menzies D
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2079-86. PubMed ID: 11112118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of entry screening in case finding of tuberculosis among asylum seekers in Norway.
    Harstad I; Jacobsen GW; Heldal E; Winje BA; Vahedi S; Helvik AS; Steinshamn SL; Garåsen H
    BMC Public Health; 2010 Nov; 10():670. PubMed ID: 21050453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis screening and follow-up of asylum seekers in Norway: a cohort study.
    Harstad I; Heldal E; Steinshamn SL; Garåsen H; Jacobsen GW
    BMC Public Health; 2009 May; 9():141. PubMed ID: 19442260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees.
    Dasgupta K; Menzies D
    Eur Respir J; 2005 Jun; 25(6):1107-16. PubMed ID: 15929967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using country of origin to inform targeted tuberculosis screening in asylum seekers: a modelling study of screening data in a German federal state, 2002-2015.
    Bozorgmehr K; Preussler S; Wagner U; Joggerst B; Szecsenyi J; Razum O; Stock C
    BMC Infect Dis; 2019 Apr; 19(1):304. PubMed ID: 30943917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description of the largest cluster of tuberculosis notified in Norway 1997-2011: is the Norwegian tuberculosis control programme serving its purpose for high risk groups?
    Guzman Herrador BR; Rønning K; Borgen K; Mannsåker T; Dahle UR
    BMC Public Health; 2015 Apr; 15():367. PubMed ID: 25879411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis case finding based on symptom screening among immigrants, refugees and asylum seekers in Rome.
    Sañé Schepisi M; Gualano G; Fellus C; Bevilacqua N; Vecchi M; Piselli P; Battagin G; Silvestrini G; Attanasio A; Vela A; Rocca G; Rinaldi A; Benedetti P; Geraci S; Lauria FN; Girardi E
    BMC Public Health; 2013 Sep; 13():872. PubMed ID: 24053349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis screening among newly arrived asylum seekers in Denmark.
    Langholz Kristensen K; Norredam M; Graff Jensen S; Seersholm N; Jørgensen ML; Exsteen BB; Huber FG; Munk-Andersen E; Lillebaek T; Ravn P
    Infect Dis (Lond); 2022 Nov; 54(11):819-827. PubMed ID: 36000199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of high resolution computed tomography with interferon-gamma release assay for tuberculosis contact investigation.
    Kowada A
    Eur J Radiol; 2013 Aug; 82(8):1353-8. PubMed ID: 23489981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Find and treat or find and lose? Tuberculosis treatment outcomes among screened newly arrived asylum seekers in Germany 2002 to 2014.
    Kuehne A; Hauer B; Brodhun B; Haas W; Fiebig L
    Euro Surveill; 2018 Mar; 23(11):. PubMed ID: 29560856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.
    Pooran A; Booth H; Miller RF; Scott G; Badri M; Huggett JF; Rook G; Zumla A; Dheda K
    BMC Pulm Med; 2010 Feb; 10():7. PubMed ID: 20170555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants.
    Porco TC; Lewis B; Marseille E; Grinsdale J; Flood JM; Royce SE
    BMC Public Health; 2006 Jun; 6():157. PubMed ID: 16784541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015.
    Bozorgmehr K; Wahedi K; Noest S; Szecsenyi J; Razum O
    Euro Surveill; 2017 Oct; 22(40):. PubMed ID: 29019315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of cost and cost-effectiveness of different TB-screening strategies.
    Nienhaus A; Schablon A; Costa JT; Diel R
    BMC Health Serv Res; 2011 Sep; 11():247. PubMed ID: 21961888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis.
    Macintyre CR; Plant AJ; Hendrie D
    Health Econ; 2000 Jul; 9(5):411-21. PubMed ID: 10903541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.